POMHEX

CAS No. 2004714-34-3

POMHEX( —— )

Catalog No. M34848 CAS No. 2004714-34-3

Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 225 Get Quote
5MG 345 Get Quote
10MG 512 Get Quote
25MG 803 Get Quote
50MG 1086 Get Quote
100MG 1458 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    POMHEX
  • Note
    Research use only, not for human use.
  • Brief Description
    Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.
  • Description
    POMHEX, a racemic mixture and a cell-permeable pivaloyloxymethyl (POM) proagent of HEX, is a potent, ENO2-specific inhibitor of enolase. POMHEX exhibits low-nanomolar potency against ENO1-deleted cells in vitro and is capable of eradicating ENO1-deleted xenografted tumours in vivo. POMHEX is a potent glycolysis inhibitor.
  • In Vitro
    Cell Proliferation Assay Cell Line:ENO1-deleted (D423, red), ENO1-isogenically rescued (D423 ENO1, blue) and ENO1-WT (LN319, grey) cells.Concentration:78 nM.Incubation Time:8 h.Result:Down-regulated cell density.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2004714-34-3
  • Formula Weight
    423.4
  • Molecular Formula
    C17H30NO9P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (236.18 mM; Ultrasonic )
  • SMILES
    O=C(OCOP(=O)(OCOC(=O)C(C)(C)C)C1C(=O)N(O)CCC1)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yu-Hsi Lin, et al. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2020 Nov 23.?
molnova catalog
related products
  • Naringinase

    Naringinase, a hydrolytic enzymatic complex, possesses the activity of both α-L-rhamnosidase and β-D-glucosidase. Naringinase has wide occurrence in nature. Naringinase can be used in the biotransformation of steroids, antibiotics, and mainly on glycoside

  • (1S,2R)-Globalagliat...

    (1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.

  • YZ9

    Y29 is a potent PFKFB3 inhibitor with an IC50 of 0.183 μM, and acts as a competitive inhibitor against Fru-6-P with a Ki of 0.094 μM.